FDA Clearance Tracker · P030016-S048
VISIAN ICL (IMPLANTABLE COLLAMER LENS)
Last checked: Nov 20, 2026Latest source record: Nov 14, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 14, 2025
Approved
Time to decision
273 days
Received Feb 14, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030016-S048
- Device name
- VISIAN ICL (IMPLANTABLE COLLAMER LENS)
- Applicant
- STAAR Surgical Company
- Applicant location
- Monrovia, CA
- Received
- Feb 14, 2025
- Decided
- Nov 14, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030016
Device type
- Device type
- Lens, intraocular, phakic (MTA)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for expanding the indicated age range from 21-45 years old to 21-60 years old for the EVO/EVO+ ICL/TICL.
Source documents
Other decisions for STAAR Surgical Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EVO/EVO+VISIAN Implantable Collamer LensPMA supplement
P030016-S035 · Decided Mar 25, 2022 · 1,240 days after receipt · Panel Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.